elevance stock price: Elevance Health (ELV) market overview

This article explains the elevance stock price — i.e., Elevance Health (NYSE: ELV) share price — covering where to find real-time quotes, historical performance, key drivers, valuation metrics, div...

2024-07-17 06:51:00

By Blockchain Lexicon

Article rating

4.5

117 ratings

Bitget offers a variety of ways to buy or sell popular cryptocurrencies. Buy now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Elevance Health stock price

Note: This article discusses the term "elevance stock price" as a common query referring to Elevance Health, Inc. (NYSE: ELV). It summarizes how to read the stock price, where to obtain quotes, factors that drive price changes, and recent company developments. Readers will learn how to check live and historical prices, interpret valuation metrics, and identify important news catalysts relevant to ELV market moves.

Company background

The search phrase "elevance stock price" refers to Elevance Health, a large U.S. health benefits company formerly known by another name. Elevance operates major businesses that affect revenue and profitability — including health benefits plans, pharmacy and care services operations, and related care-management businesses. Company fundamentals such as enrollment trends, premium pricing, medical-cost trends and growth in care services influence the elevance stock price through revenue, margins and earnings-per-share dynamics.

Ticker symbol and exchange

When people search for "elevance stock price," they are looking for the price of Elevance Health shares trading under the ticker ELV on the New York Stock Exchange (NYSE). Trading conventions to note when checking the elevance stock price:

Primary ticker: ELV
Primary exchange: NYSE (regular trading hours, pre-market and after-hours sessions may also show extended trading prices)
For trading and custody, consider regulated venues; for retail execution and derivatives, Bitget is suggested as a trading platform to explore (note: this article does not provide investment advice).

Real-time price and quote providers

If you search "elevance stock price" you will commonly see quotes from a mix of providers. Popular public quote providers include company investor relations pages, major finance portals, and broker platforms. Typical data caveats:

Many free providers display delayed data (often ~15–20 minutes) unless explicitly marked as real-time. Always check the data disclaimer.
Extended-hours prices (pre-market and after-hours) may differ from regular-session closing prices and are often shown separately.

Common sources when checking the elevance stock price include:

Elevance Health investor relations stock page for company-provided information and official filings
Financial news quote pages and market data portals for near real-time and delayed quotes
Broker or trading platforms for executable prices (for retail traders, Bitget is an available platform to view and trade equities and related products)

When looking up the elevance stock price, confirm whether the price shown is regular-hours, pre-market, or after-hours.

Historical price performance

The elevance stock price has been shaped by multi-year trends in healthcare demand, changes in government program payments, and company-specific events. To analyze historical performance, investors commonly examine the following:

Long-term price charts (1, 3, 5, 10+ years)
52-week high and low ranges
Major inflection points tied to earnings, guidance changes, mergers, rebranding or regulatory shifts

Reliable data sources for historical series when researching the elevance stock price include long-term chart providers and data aggregators. These sources typically provide OHLC (open-high-low-close) daily data, adjusted for splits and dividends.

Long-term trends and milestones

Major price milestones for the elevance stock price often align with the company’s strategic changes and industry-wide developments. Examples of items that historically impact ELV price levels:

Corporate rebranding or structural changes that alter investor perception
Large M&A transactions or divestitures that reshape future cash flows
Sustained shifts in medical cost trends and membership mixes that materially affect margins

When reviewing the elevance stock price history, check adjusted charts to account for dividends, buybacks and any stock splits to measure total shareholder return accurately.

Recent performance and intraday/short-term movements

Short-term moves in the elevance stock price are typically driven by quarterly results, guidance updates, and regulatory or policy news. Intraday statistics you will see when tracking the elevance stock price include open, intraday high/low, last trade, volume, and the bid/ask spread. News such as earnings beats or misses, guidance revisions, or sudden industry-wide developments can cause amplified intraday volatility.

As of Jan 28, 2026, Reuters reported that Elevance Health issued guidance that signaled near-term pressure on revenue and profit expectations, which drove a sizable share-price reaction before the market open. That public guidance and related market response are discussed in the Key Price Drivers section below.

Key price drivers and news catalysts

When searching for "elevance stock price," it helps to understand the principal drivers that can move the share price:

Quarterly earnings and forward guidance: Changes to profit and revenue outlooks directly impact the elevance stock price.
Medical-cost trends and medical loss ratio (MLR): Rising claims and higher utilization increase the MLR, compressing margins and weighing on the elevance stock price.
Government program rates and regulatory policy: Payments for Medicare Advantage, Medicaid policies, and Affordable Care Act (ACA) premium subsidies can materially impact revenue and membership profiles, thus affecting the elevance stock price.
Membership mix and premium pricing: Enrollment shifts (for example, lower enrollment among healthier members) and premium-setting actions alter expected profitability and the elevance stock price.
Analyst ratings and price-target changes: Upgrades/downgrades and target revisions influence investor sentiment and the elevance stock price.
M&A, strategic initiatives and new business growth (e.g., care-services expansion) that affect future earnings power and the elevance stock price.

Recent, verifiable example (reported):

As of Jan 28, 2026, Reuters reported that Elevance expects total operating revenue to decline by a low-single-digit percentage in 2026 and forecasted 2026 adjusted profit below Wall Street consensus; the announcement led to a >7% pre-market decline in the shares. The company cited elevated medical costs and membership shifts as contributors to the outlook. These developments directly impacted the elevance stock price on the reporting date.

Financial metrics and valuation indicators

Common financial metrics investors check when evaluating the elevance stock price include:

Market capitalization: overall company value based on outstanding shares and the elevance stock price
Price-to-earnings (P/E) ratio and forward P/E
Earnings per share (EPS) — trailing and adjusted forward estimates
Revenue and revenue growth rates
Profit margins and net margin trends
Dividend yield and payout ratios
Beta (historical volatility relative to the market)

These metrics are widely available from company filings and financial data providers. When interpreting valuation ratios, ensure that earnings (numerator or denominator) are comparable across periods and that one-time items are adjusted appropriately.

Dividends, splits and shareholder returns

Elevance has historically returned capital through dividends and buyback programs, both of which influence the per-share price and total shareholder return. For the latest dividend amount, ex-dividend dates, and any announced stock splits or buyback authorizations, consult the company investor relations disclosures and confirmed market-data feeds.

Dividend distributions reduce the closing share price on the ex-dividend date by the amount of the cash dividend in theory; therefore, when tracking the elevance stock price over time, check whether charts are adjusted for dividends to accurately assess returns.

Trading statistics and liquidity

Key trading statistics that matter when monitoring the elevance stock price:

Average daily trading volume: higher volume generally improves liquidity and narrows bid/ask spreads
Typical bid/ask spreads during regular trading and extended sessions
Institutional ownership levels: high institutional ownership can influence volatility during fund rebalancings

When trading around major news that moves the elevance stock price (earnings, guidance, regulatory updates), intraday spreads and price impact may widen due to heightened order flow.

Analyst coverage and price targets

Analyst reports and consensus price targets are frequently cited by market participants searching for "elevance stock price." Changes in coverage, rating or targets can influence sentiment and cause notable moves in the share price. Major analyst comments that accompany guidance or guidance misses often prompt immediate re-pricing in the elevance stock price.

Example from recent reporting:

Market reaction following the Jan 28, 2026 guidance included analyst commentary noting pressure in Medicaid and the effect of lower-than-expected Medicare Advantage payments; such analyst notes contributed to the share-price reaction observed that day.

Risks and regulatory considerations

Principal risks that can affect the elevance stock price include:

Regulatory and policy risks: changes in government program payments for Medicare Advantage, Medicaid, and ACA risk-adjusted payments
Medical-cost volatility: unexpected increases in utilization or specialty drug costs can raise the medical loss ratio and depress margins
Membership mix and premium elasticity: shifts in who enrolls (healthier vs. sicker members) alter expected claims costs and the elevance stock price
Litigation and compliance risks: legal or compliance actions can create downside pressure on the elevance stock price
Macroeconomic and market risks: interest rates, equity market risk appetite, and sector rotations affect share-price performance

All such risks are factual influences; this article is neutral and not providing investment advice.

How to find historical quotes and charts

When researching the elevance stock price, use multiple reputable sources for cross-checking:

Company investor relations: official filings, earnings releases and presentations
Financial portals that provide historical adjusted price series and downloadable data for the elevance stock price
Long-term chart and analytics platforms for multi-year performance comparisons and technical studies
Broker/trading platforms for executable-level prices and extended-hours data (Bitget is a platform to consider when seeking trade execution capabilities)

Note: Verify whether data is delayed and whether charts are adjusted for corporate actions when analyzing the elevance stock price.

Recent company developments and market context (reported items)

As of Jan 28, 2026, Reuters reported the following points about Elevance Health that are relevant to the elevance stock price:

Guidance and revenue expectations: Elevance said it expects total operating revenue to decline by a low-single-digit percentage in 2026 and forecasted full-year adjusted profit below street estimates. The company indicated elevated medical costs will continue to weigh on insurers.
Profit outlook: Elevance forecast 2026 adjusted profit to be at least $25.50 per share, below analysts' estimates of $26.90 per share.
Medical loss ratio and cost trends: The company reported a medical loss ratio of 93.5% for the quarter, reflecting higher demand in certain individual plans. The company expects its 2026 medical loss ratio to be about 90.2% ± 50 basis points.
Membership effects: Elevance noted a low-double-digit decline in membership in some plans, partly offset by higher premiums and growth in its care-services business.
Market reaction: The guidance and commentary led to an early pre-market drop of more than 7% in the shares on the Reuters report date.
Quarterly results context: Fourth-quarter adjusted EPS of $3.33 beat estimates of $3.10, while quarterly operating revenue of $49.3 billion missed an estimate of $49.82 billion.

These reported, dated figures are verifiable in company releases and Reuters coverage and directly inform short-term movements in the elevance stock price.

Practical checklist when tracking the elevance stock price

When you look up the elevance stock price, use this checklist to ensure clarity and context:

Confirm the timestamp and whether the quote is regular-hours, pre-market, or after-hours.
Check whether the provider displays real-time or delayed data and note any stated delay.
Review the company’s latest earnings release, guidance and investor presentation for drivers of the elevance stock price.
Check the medical loss ratio, membership trends and guidance commentary — these items materially affect forecasts and the elevance stock price.
Look at analyst notes and consensus estimates for EPS and revenue to compare market expectations vs. company guidance.
Verify average daily volume and institutional ownership to assess liquidity and potential price impact.
If planning to trade, confirm execution venue, margin requirements and settlement rules on the chosen platform (Bitget is available as a trading platform to consider).

References and data sources

Primary sources to verify numbers and charts for the elevance stock price include:

Elevance Health investor relations stock information and SEC filings
Major financial news outlets and market-data portals for quotes and news
Long-term data providers for historical adjusted prices and dividends
Trading platforms for executable prices and intraday liquidity

All figures cited in this article (for example, the Jan 28, 2026 Reuters-sourced guidance and metrics) were reported by the stated news source on the noted date. When verifying the elevance stock price for trading or academic purposes, consult primary filings and real-time market data.